Navigation Links
PG500 Series Presented at the AACR Annual Meeting in San Diego
Date:4/13/2008

BRISBANE, Australia, April 14 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL) (Nasdaq: PGLA) announced today that it had presented new data on its patented PG500 series of compounds at the annual American Association for Cancer Research (AACR) meeting being held in San Diego. The meeting brings together approximately 17,000 participants from around the world to discuss new and significant advances in the knowledge surrounding the causes, diagnosis, treatment and prevention of cancer.

The data presented shows that this series of heparan sulfate mimetic compounds have very strong inhibition of angiogenesis and metastasis and strong anti-tumor activity in some aggressive tumor models. The data firmly supports the continued pre-clinical development of this new series of compounds as anti-cancer agents.

PG545 has been chosen as the lead candidate for additional studies required to support an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA). Dr. Anand Gautam, Vice President, Drug Discovery, stated, "PG545 was selected over and above other compounds based on a comprehensive target product profile incorporating aspects such as efficacy, pharmacokinetics, toxicology and ease of manufacture."

Depending upon the outcome of these further studies we expect to submit an IND application with the US-FDA late this calendar year, or early 2009.

About Progen: Progen Pharmaceuticals is a globally focused biotechnology company committed to the discovery, development and commercialization of small molecule pharmaceuticals primarily for the treatment of cancer. Progen has operations in Australia and the US.

About the PG500 series: Progen has an innovative small molec
'/>"/>

SOURCE Progen Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioVascular Inc. Closes $10.87 Million Series C Financing
2. Globus Medical Raises $110 Million in Series E Financing Round
3. Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
4. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
5. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
6. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
7. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
10. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
11. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)...  - MediaLINC unlocks ... Lincor announced general availability of MediaLINC - ... range of education, entertainment and clinical content direct to ... , " Lincor has already ... engagement to bedside smart devices, " comments Dan ...
(Date:8/21/2014)... Aug. 21, 2014  Aptuit LLC announces that ... Indiana , has enhanced its capabilities in ... small and large molecules, including biologic drugs, metabolites, ... maXisPlus Q-TOF mass spectrometer. In making ... Aptuit, said, "The expanded large molecule capability enhances ...
(Date:8/21/2014)... , Aug. 21, 2014 The spinal column is ... human body. Signals carried to and from the brain through ... and nervous system. Injury or ailment here can be life ... a loss of control over their body. Though back injury ... person,s life, there are more options available to make things ...
Breaking Medicine Technology:Lincor Unveils Next Generation TV-based Patient Engagement Solution 2Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2
... Demonstrates Commitment to Patient Safety; Approved Sites Eligible to Advertise through ... , , ... July 28 The National Association of Boards of Pharmacy ... Kerr Drug as the first online pharmacy services to be approved ...
... , BOCA RATON, Fla. , July 28 ... with Tris Pharma, the company will market Methylphenidate Solution, ... Inc., under an Abbreviated New Drug Application (ANDA).  Under ... manufactured by Tris Pharma, and marketed and distributed by ...
Cached Medicine Technology:NABP Grants First 'Approved e-Advertiser' Status to Pharmahelper.com, QC Supply, and Kerr Drug 2NABP Grants First 'Approved e-Advertiser' Status to Pharmahelper.com, QC Supply, and Kerr Drug 3Breckenridge Pharmaceutical to Market Methylphenidate Oral Solution Through Agreement With Tris Pharma (Monmouth Junction, NJ) 2
(Date:8/22/2014)... (PRWEB) August 23, 2014 Recently, iFitDress.com, ... its new collection of discounted wedding gowns . ... announced that all these new products are provided with ... are very happy to unveil the new wedding gowns. ... special occasion gowns for ladies to choose from. What’s ...
(Date:8/22/2014)... The LSU Health New Orleans School of ... Traineeship grant to increase access to advanced nursing ... under-represented groups, as well as veterans. The Health ... of Health and Human Services awarded the two-year ... the grant,s project director., The Advanced Education Nursing ...
(Date:8/22/2014)... Natural Clear Vision , a how-to guide ... vision from legally blind to perfect 20/20 vision has caught ... , “There is a huge portion of the population today ... most people just think that’s the way it will always ... be pretty risky at times,” reports Michaels. “This program is ...
(Date:8/22/2014)... somatic mutation at amino acid 918 in the RET ... cell lung cancer (SCLC) tumors and enforced expression of ... signaling and cell growth. , SCLC is a highly ... lung cancers and is strongly associated with tobacco smoking. ... examined for genomic alterations and targeted therapies are approved ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Restore ... Sen and Dr. Samantha Pearson to help people discover ... avoid corrective vision surgery by instead improving their eyesight ... an investigative review. , “There’s a reason why ... in revenue each year—it’s because people just assume that ...
Breaking Medicine News(10 mins):Health News:Discounted Wedding Gowns For Sale At Leading Online Shop iFitDress.com 2Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2
... Delhi went on mass casual leave Monday, joining ... the sufferings of patients. ,The majority of ... University College of Medical Sciences (UCMS) and Safdarjung ... resentment against the government decision to implement 27 ...
... zero alcohol quotient is highly conducive for the cognitive ... research has suggested//. Infact, even moderated alcohol intake during ... unborn child. ,The study conducted by the University ... Washington, has shown that those children, whose mothers had ...
... over 3500 and an incalculable number of people injured after ... cope with the injured and the dead. ,The quake ... city of Yogyakarta which is near the southern coast of ... left the city in shambles, cutting off communications and road ...
... American study conducted by Arthur Krigsman, of New York ... links to autism//. MMR inoculation is given to young ... But recently there have been claims that the vaccine ... fall in the MMR vaccine uptake rate which has ...
... the world and it has drastically affected the sales of chicken ... for chicken// and the sales are slowly picking up in the ... stage. ,Mohamed Al Shafei, director of the General Union ... great deal in the past with a large number of chickens ...
... very similar to the technology in the United States, and ... for filling up nursing vacancies. With India also being rated ... are realizing their dream of seeking greener pastures. , ... from India who will be joining the hospital during this ...
Cached Medicine News:Health News:Mass Leave By Doctors Leaves Patients Helpless 2Health News:Indonesian Earthquake – Story of Destruction, Death and Disease 2
... replace the carpal scaphoid bone. The implant has ... under a shelf formed in the carpal trapezium ... the proximal hole for suture fixation. These temporarily ... period until a firm capsuloligamentous system has formed ...
... has the same anatomical configuration as the ... to provide for stability. The implant has ... use in suture fixation through the scaphoid ... while a capsuloligamentous system forms around the ...
... for four corner fusion of the capitate, ... hand. The plate is intended for use ... of function due to SLAC and SNAC ... rheumatoid arthritis. When combined with the specially ...
The 3.0 mm Cannulated Screw can be used with or without threaded washer. Uses 1.1 mm threaded or non-threaded guide wire. , ,The Threaded Washer provides a recessed internal buttress which allows the...
Medicine Products: